JP2023524016A5 - - Google Patents

Info

Publication number
JP2023524016A5
JP2023524016A5 JP2022565960A JP2022565960A JP2023524016A5 JP 2023524016 A5 JP2023524016 A5 JP 2023524016A5 JP 2022565960 A JP2022565960 A JP 2022565960A JP 2022565960 A JP2022565960 A JP 2022565960A JP 2023524016 A5 JP2023524016 A5 JP 2023524016A5
Authority
JP
Japan
Prior art keywords
mir
hsa
mirna
cell proliferation
colorectal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022565960A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524016A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/029361 external-priority patent/WO2021222220A2/en
Publication of JP2023524016A publication Critical patent/JP2023524016A/ja
Publication of JP2023524016A5 publication Critical patent/JP2023524016A5/ja
Pending legal-status Critical Current

Links

JP2022565960A 2020-04-29 2021-04-27 結腸細胞増殖性障害を特定するためのｒｎａマーカと方法 Pending JP2023524016A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063017552P 2020-04-29 2020-04-29
US63/017,552 2020-04-29
US202063024875P 2020-05-14 2020-05-14
US63/024,875 2020-05-14
PCT/US2021/029361 WO2021222220A2 (en) 2020-04-29 2021-04-27 Rna markers and methods for identifying colon cell proliferative disorders

Publications (2)

Publication Number Publication Date
JP2023524016A JP2023524016A (ja) 2023-06-08
JP2023524016A5 true JP2023524016A5 (enExample) 2024-05-10

Family

ID=78332157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565960A Pending JP2023524016A (ja) 2020-04-29 2021-04-27 結腸細胞増殖性障害を特定するためのｒｎａマーカと方法

Country Status (8)

Country Link
US (1) US20230160019A1 (enExample)
EP (1) EP4143309A4 (enExample)
JP (1) JP2023524016A (enExample)
KR (1) KR20230017206A (enExample)
CN (1) CN115812101A (enExample)
AU (1) AU2021263680A1 (enExample)
CA (1) CA3181389A1 (enExample)
WO (1) WO2021222220A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019060716A1 (en) 2017-09-25 2019-03-28 Freenome Holdings, Inc. SAMPLE EXTRACTION METHODS AND SYSTEMS
KR20220015367A (ko) 2019-05-31 2022-02-08 프리놈 홀딩스, 인크. 메틸화된 핵산의 고심도 시퀀싱 방법 및 시스템
AU2021245992A1 (en) 2020-03-31 2022-11-10 Freenome Holdings, Inc. Methods and systems for detecting colorectal cancer via nucleic acid methylation analysis
CN116670510A (zh) 2020-10-05 2023-08-29 福瑞诺姆控股公司 用于结肠细胞增殖性病症的早期检测的标志物
CA3202255A1 (en) 2020-12-21 2022-06-30 Hayley WARSINSKE Markers for the early detection of colon cell proliferative disorders
JP2025517309A (ja) 2022-05-17 2025-06-05 ガーダント ヘルス， インコーポレイテッド 創薬可能な標的を特定するための方法およびがんを処置するための方法
WO2024009221A1 (en) * 2022-07-04 2024-01-11 Artificial Intelligence Expert Srl Method and system for multi-cancer management in subject
US11992318B2 (en) * 2022-07-13 2024-05-28 Celestin B. Bitjonck Diagnostic lab-on-a-chip device
CN118048450A (zh) * 2022-11-15 2024-05-17 杭州诺辉健康科技有限公司 使用miRNA亚型的家族占比检测癌症
US12587274B2 (en) 2023-03-28 2026-03-24 Quantum Generative Materials Llc Satellite optimization management system based on natural language input and artificial intelligence
US12368503B2 (en) 2023-12-27 2025-07-22 Quantum Generative Materials Llc Intent-based satellite transmit management based on preexisting historical location and machine learning
US12603701B2 (en) 2023-12-27 2026-04-14 Quantum Generative Materials Llc Distributed satellite constellation management and control system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100010196A1 (en) * 1997-09-26 2010-01-14 Abt Holding Company Compositions and methods for non-targeted activation of endogenous genes
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
NZ593226A (en) * 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (efnb2) for colorectal cancer prognosis
EP2336353A1 (en) * 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases
JP2013526852A (ja) * 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
WO2011128900A2 (en) * 2010-04-15 2011-10-20 Hadasit Medical Research Services And Development Ltd. Early detection and staging of colorectal cancer using a panel of micro rnas
US20120088687A1 (en) * 2010-10-08 2012-04-12 Baylor Research Institute MicroRNAs (miRNA) as Biomarkers for the Identification of Familial and Non-Familial Colorectal Cancer
EP2718463B1 (en) * 2011-06-08 2016-01-20 Comprehensive Biomarker Center GmbH Complex sets of mirnas as non-invasive biomarkers for dilated cardiomyopathy
US20160076098A1 (en) * 2013-04-12 2016-03-17 Drexel University Methods of diagnosing and treating chronic pain
EP3256607B1 (en) * 2015-02-13 2021-01-20 Patel, Abhijit Ajit Methods for highly parallel and accurate detection of nucleic acids
US10577645B2 (en) * 2016-03-18 2020-03-03 Norgen Biotek Corp. Methods and kits for improving global gene expression analysis of human blood, plasma and/or serum derived RNA
ES3002715T3 (en) * 2016-04-14 2025-03-07 Guardant Health Inc Methods for early detection of cancer
EP3571315B1 (en) * 2017-01-23 2025-01-08 Gatehouse Bio, Inc. Methods for identifying and using small rna predictors
AU2018243360B2 (en) * 2017-03-29 2023-10-26 Cornell University Devices, processes, and systems for determination of nucleic acid sequence, expression, copy number, or methylation changes using combined nuclease, ligase, polymerase, and sequencing reactions
JP7455757B2 (ja) * 2018-04-13 2024-03-26 フリーノーム・ホールディングス・インコーポレイテッド 生体試料の多検体アッセイのための機械学習実装

Similar Documents

Publication Publication Date Title
JP2023524016A5 (enExample)
US12584162B2 (en) Hydroxymethylation analysis of cell-free nucleic acid samples for assigning tissue of origin, and related methods of use
US10138520B2 (en) Diagnostic miRNA markers for Alzheimer
US11111541B2 (en) Diagnostic MiRNA markers for Parkinson's disease
Keller et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls
JP6702935B2 (ja) 胃がん診断用のマイクロｒｎａバイオマーカー
Slattery et al. MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression
JP2023524016A (ja) 結腸細胞増殖性障害を特定するためのｒｎａマーカと方法
CN103952474B (zh) 一种食管癌诊断标志物及其使用方法
Pan et al. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma
EP2733220A1 (en) Novel miRNAs as diagnostic markers
EP4306656A1 (en) Cancer test reagent set, method for producing cancer test reagent set, and cancer test method
CN104073569A (zh) 用于诊断手足口病极重症的分子标记物及其检测方法与试剂盒
US20240254566A1 (en) Analysis method, kit, and detection device
CN105779580A (zh) 评估罹患结肠直肠癌风险的方法及标志物
JP2026502347A (ja) 肺がんの検出のための循環バイオマーカーおよびその方法
CN118043670A (zh) 随机表观基因组采样
Rao et al. MutSigCVsyn: identification of thirty synonymous cancer drivers
CN108531571A (zh) 用于检测注意力缺陷/过动症的方法和试剂盒
Eshed et al. Information Theory-Guided Detection of Biomarkers Using Programmable Aptamer Arrays
JP2024527370A5 (enExample)
JP2025080817A (ja) 分析方法、マーカー及びキット
WO2019002536A1 (en) NOVEL ARNMI-BASED BIOMARKERS AND THEIR USE